➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
McKinsey
Medtronic
Boehringer Ingelheim
AstraZeneca

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

GARDASIL Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: GARDASIL
Patents:9
Applicants:2
BLAs:2
Suppliers: see list2
Recent Clinical Trials: See clinical trials for GARDASIL
Recent Clinical Trials for GARDASIL

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Boston Medical CenterPhase 4
Merck Sharp & Dohme Corp.Phase 3
University Health Network, TorontoPhase 1

See all GARDASIL clinical trials

Patent Text Search: US Patents for GARDASIL

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
A-s Medication Solutions GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Get Started Free SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 search
A-s Medication Solutions GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Get Started Free Evrys Bio, LLC (Doylestown, PA) 2040-02-29 search
A-s Medication Solutions GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Get Started Free Marbley; Theodore C. (Palm Springs, CA) 2035-07-21 search
A-s Medication Solutions GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Get Started Free SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 search
A-s Medication Solutions GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Get Started Free Chevron Phillips Chemical Company LP (The Woodlands, TX) 2031-06-06 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Colorcon
Boehringer Ingelheim
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group